Feeds

Pfizer sues online pharmacies

US patent infringement allegations

  • alert
  • submit to reddit

Secure remote control for conventional and virtual desktops

Pfizer has filed lawsuits against five online pharmacies for selling an unapproved copy of Pfizer's top-selling cholesterol medicine - Lipitor - the company says in a statement.

The suits were filed in US district courts in Delaware and Connecticut against Generic Lipitors, Online Rx DrugStore, WorldMedsRX, B. M. International, and Offshore Pharma.

Pfizer says the sites market a product called Storvas, which is advertised as being manufactured by Ranbaxy Pharmaceuticals Inc of India, a country that doesn't recognise drug patents.

The Pfizer lawsuits claim damages for infringement of Pfizer's patent and trademark rights for Lipitor. The complaints also seek to remove references to Lipitor in advertising materials and to eliminate computer links that misdirect patients to an illegal, unapproved product.

This is the first time a big pharmaceutical firm has tried to halt the sale of illegal generic medicines on the Net. Many dubious online pharmacies, companies which typically fail to provide a contact address or phone number, often sell 'generic variations' of medicines, in particular generic or herbal Viagra. The only FDA-approved brand, however, is Viagra produced by Pfizer, which owns the patent on its active ingredient.

The US Food and Drug Administration (FDA) gets dozens of reports of counterfeit drugs. They may look like the medicines the doctor would prescribe, but they often contain little or no active ingredients, or additional ingredients that could have serious side-effects.

Pfizer filed another suit on 12 April against Look4Generics.com in US District Court in Delaware. The company noted that the Internet provides easy access to websites that sell unapproved or counterfeit pharmaceutical products that could put patient health at risk. ®

Related stories

Big Pharma puts squeeze on Canadian Net pharmacies
E-pharmacies guilty of blatant disregard for health
Drugs agency calls for crackdown in e-pharmacies
Legality of online pharmacies questioned
Unscrupulous Net drugs trade led to death of student
e-Pharmacy sites offer risky prescription
Internet pharmacies draw fire on Capitol Hill

Top 5 reasons to deploy VMware with Tegile

More from The Register

next story
MI6 oversight report on Lee Rigby murder: US web giants offer 'safe haven for TERRORISM'
PM urged to 'prioritise issue' after Facebook hindsight find
Assange™ slumps back on Ecuador's sofa after detention appeal binned
Swedish court rules there's 'great risk' WikiLeaker will dodge prosecution
NSA mass spying reform KILLED by US Senators
Democrats needed just TWO more votes to keep alive bill reining in some surveillance
'Internet Freedom Panel' to keep web overlord ICANN out of Russian hands – new proposal
Come back with our internet! cries Republican drawing up bill
What a Mesa: Apple vows to re-use titsup GT sapphire glass plant
Commits to American manufacturing ... of secret tech
prev story

Whitepapers

Why cloud backup?
Combining the latest advancements in disk-based backup with secure, integrated, cloud technologies offer organizations fast and assured recovery of their critical enterprise data.
Forging a new future with identity relationship management
Learn about ForgeRock's next generation IRM platform and how it is designed to empower CEOS's and enterprises to engage with consumers.
Designing and building an open ITOA architecture
Learn about a new IT data taxonomy defined by the four data sources of IT visibility: wire, machine, agent, and synthetic data sets.
How to determine if cloud backup is right for your servers
Two key factors, technical feasibility and TCO economics, that backup and IT operations managers should consider when assessing cloud backup.
Reg Reader Research: SaaS based Email and Office Productivity Tools
Read this Reg reader report which provides advice and guidance for SMBs towards the use of SaaS based email and Office productivity tools.